Anthera Pharmaceuticals ( ANTH ) Q1 2013 Earnings Call May 20, 2013 5:00 pm ET Executives ..... http://seekingalpha.com/article/1448541-anthera- pharmaceuticals -management-discusses-q1-2013-results-earnings-call
(Reuters) - A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc .
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc.
Spectrum Pharmaceuticals , Inc. ( SPPI ) May 20, 2013 ..... President and CEO of Spectrum Pharmaceuticals . We will have a breakout session ..... the West Coast called Spectrum Pharmaceuticals . We are focused on oncology
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap.
Astex Pharmaceuticals , Inc. ( ASTX ) May 20, 2013 ..... Manuso, Chairman and CEO of Astex Pharmaceuticals . There will be a breakout session ..... com/article/1448421-astex- pharmaceuticals -inc-presents-at-ubs-global
Ironwood Pharmaceuticals ( IRWD ) announces a 10.5M share public offering , with a 30-day option to purchase up to an additional 1,575,000 shares
Cubist Pharmaceuticals ( CBST +11.3% ) spikes to session highs. The move appears relates to an apparent Markman ruling on Hospira (HSP +0.7
By Jean-Christophe Larsimont: What remains in the pipeline of the eighth largest pharmaceuticals company after the recent approval of its last jackpot ? Introduction You will find a comprehensive dividend stock analysis of Johnson
Regeneron Pharmaceuticals , Inc. ( REGN ) May 20, 2013 10:00 am ET Executives Murray ..... http://seekingalpha.com/article/1447681-regeneron- pharmaceuticals -inc-presents-at-ubs-global-healthcare-conference